These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 5396159)

  • 1. [Therapeutic effects of CS 1507 in mammary gland cancer].
    Pinel P
    Therapeutique; 1969 Dec; 45(10):1009-11. PubMed ID: 5396159
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of disseminated mammary carcinoma with drostanolone propionate.
    Brown IG
    Practitioner; 1970 Sep; 205(227):336-7. PubMed ID: 5536680
    [No Abstract]   [Full Text] [Related]  

  • 3. [The action and place of 2 alpha-methyl dihydrotestosterone in the treatment of breast cancer].
    Spithakis R
    Mars Med; 1972; 109(2):171-3. PubMed ID: 4112005
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of mastisol (2-alpha-methylandrostan-17-beta-ol-3-one propionate) and testosterone propionate in the treatment of advanced and recurrent cancer of the breast.
    Amaaki T; Enomoto K; Shimada S; Nagai K; Minagawa N
    Nihon Geka Hokan; 1969 Jul; 38(4):652-7. PubMed ID: 5394603
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of breast cancer in aged women].
    Berta V; Perelli-Ercolini M; Beani G
    Chir Ital; 1980 Dec; 32(6):1543-51. PubMed ID: 6894717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of drostanolone propionate (Masteril) and nandrolone decanoate (Deca-durabolin) in the treatment of breast carcinoma.
    Chowdhury MS; Banks AJ; Bond WH; Jones WG; Ward HW
    Clin Oncol; 1976 Sep; 2(3):203-6. PubMed ID: 1036981
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of dromostanolone propionate for mastopathy--with special reference to screening of breast cancer].
    Takeuchi S; Yoshida M
    Saishin Igaku; 1967 May; 22(5):1049-54. PubMed ID: 5630583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with dromostanolone propionate (NSC-12198) in breast carcinoma.
    Seay DG; Bradshaw JD; Nicol NT
    Cancer Chemother Rep; 1972 Feb; 56(1):89-92. PubMed ID: 5067664
    [No Abstract]   [Full Text] [Related]  

  • 10. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.
    Perumal SS; Shanthi P; Sachdanandam P
    Chem Biol Interact; 2005 Feb; 152(1):49-58. PubMed ID: 15766922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and autophagy in mammary gland remodeling and breast cancer chemotherapy.
    Motyl T; Gajkowska B; Zarzyńska J; Gajewska M; Lamparska-Przybysz M
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 7():17-32. PubMed ID: 17228094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of an antitumor preparation proloteston].
    Beskrovnyĭ AM; Sof'ina ZP; Sukhacheva OA; Ushenko SN; Iurchenko MZ
    Vopr Onkol; 1983; 29(3):82-6. PubMed ID: 6687647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin and mammary pathological growth.
    Cos S; Sánchez-Barceló EJ
    Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Castration in the treatment of mammary cancer. 3. Therapeutic possibilities in mammary cancer].
    Noriega Limón J
    Gac Med Mex; 1967 Sep; 97(9):1105-11. PubMed ID: 5611986
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonal treatment of mammary tumors in rats induced by 3-methylcholanthrene (NSC-21970) and 7,12-dimethylbenz(alpha)anthracene (NSC-408823).
    Shimkin MB; Gropper L; Thatcher D; Gruenstein M
    Cancer Res; 1967 Nov; 27(11 Pt 2):1284-8. PubMed ID: 5630409
    [No Abstract]   [Full Text] [Related]  

  • 16. Can modulation of mammary gland development by dietary factors support breast cancer prevention?
    Wärri AM; Saarinen NM; Mäkelä SI
    Horm Res; 2007; 68(5):248-60. PubMed ID: 17510562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intra-arterial infusion chemotherapy for breast cancer].
    Matsumoto Y; Terakado H; Ikawa M; Hamada E; Watanabe Y; Nakasato S; Takaki S; Murata M; Miura T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1526-8. PubMed ID: 8854797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinases in mammary gland development and cancer.
    Kumar R; Wang RA
    Microsc Res Tech; 2002 Oct; 59(1):49-57. PubMed ID: 12242696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary androgen excretion is a hormonal abnormality detectable before the clinical onset of breast cancer.
    Secreto G; Recchione C; Grignolio E; Cavalleri A
    Cancer Detect Prev; 1983; 6(4-5):435-8. PubMed ID: 6652637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of sodium beta-aminoethylthiophosphate (AETP, Cystaphos) in the endoxan treatment of disseminated cancer of the mammary gland].
    Aliev RG; Bazhenova AP; Bergol'ts VM; Brin ML
    Vopr Onkol; 1967; 13(9):23-8. PubMed ID: 5599601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.